Targeting miR-21 Inhibits <i>In Vitro</i> and <i>In Vivo</i> Multiple Myeloma Cell Growth

Abstract

Our findings show the first evidence that in vivo antagonism of miR-21 exerts anti-multiple myeloma activity, providing the rationale for clinical development of miR-21 inhibitors in this still incurable disease.